The role of immune and inflammatory processes in the development of macrovascular disease in diabetes
Maria F. Lopes-Virella and Gabriel Virella
[Frontiers in Bioscience 8, s750-768, September 1, 2003]

Lipoxygenases and lipid signaling in vascular cells in diabetes
Rama Natarajan and Jerry L Nadler
[Frontiers in Bioscience 8, s783-795, September 1, 2003]

Fibrinolysis and diabetes
Burton E. Sobel
[Frontiers in Bioscience 8, d1085-1092, September 1, 2003]

How does diabetes accelerate atherosclerotic plaque rupture and arterial occlusion?
Stephen M. Schwartz and Karin E. Bornfeldt
[Frontiers in Bioscience 8, s1371-1383, September 1, 2003]

Angiotensin II, PPAR-Gamma and atherosclerosis
Ulrich Kintscher, Christopher J. Lyon and Ronald E. Law
[Frontiers in Bioscience 9, 359-369, January 1, 2004]

Mechanisms of oxidative stress in diabetes: implications for the pathogenesis of vascular disease and antioxidant therapy
Subramaniam Pennathur and Jay W. Heinecke
[Frontiers in Bioscience 9, 565-574, January 1, 2004]

Direct effects of long-chain non-esterified fatty acids on vascular cells and their relevance to macrovascular complications of diabetes
John F. Oram and Karin E. Bornfeldt
[Frontiers in Bioscience 9, 1240-1353, May 1, 2004]